Probiotics for patients with inflammatory bowel disease
Assessment of Medical and Nutritional Status Post-Probiotic Intake in Patients Diagnosed With Inflammatory Bowel Disease: A Randomized Clinical Trial
This study is testing if taking probiotics can help people with inflammatory bowel diseases like ulcerative colitis and Crohn's feel better and improve their quality of life.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 50 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | Lebanese University Academic / other |
| Locations | 1 site (Beirut) |
| Trial ID | NCT06392061 on ClinicalTrials.gov |
What this trial studies
This clinical trial evaluates the effects of probiotic administration on patients diagnosed with inflammatory bowel diseases, specifically ulcerative colitis and Crohn's disease. Conducted at ZHUMC's endoscopy unit, the study involves a randomized, single-blinded, controlled design where participants are divided into a control group and a probiotic intervention group. Over a period of two months, patients will undergo medical and nutrition surveys, along with body composition measurements, to assess the impact of probiotics on their disease progression, quality of life, and nutritional status.
Who should consider this trial
Good fit: Ideal candidates are Lebanese outpatients with a histological diagnosis of Crohn's disease or ulcerative colitis who have stable inactive disease and have not used probiotics in the two months prior to the trial.
Not a fit: Patients who are pregnant or lactating, or those who have used probiotics within the study period will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve the management and quality of life for patients with inflammatory bowel disease.
How similar studies have performed: Other studies have shown promising results with probiotic interventions in inflammatory bowel disease, suggesting potential benefits.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Lebanese outpatients with histological diagnosis of Crohn's disease or Ulcerative Colitis from at least 6 months prior to the trial. * have stable inactive disease. * have not used any probiotics within the two months before the investigation. Exclusion Criteria: * pregnant or lactating women * patients who use probiotics within the study period.
Where this trial is running
Beirut
- zahra Sadek — Beirut, Lebanon (Recruiting)
Study contacts
- Principal investigator: Mahmoud Hallal — Al Zahraa Hospital University Medical Center
- Study coordinator: zahra Sadek, PhD
- Email: zahrasadek81@hotmail.com
- Phone: +9613947985
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.